According to Supernus Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 54,608,963. At the end of 2023 the company had 54,608,963 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 54.6 M | 0.93% |
2022 | 54.1 M | 1.63% |
2021 | 53.23 M | 1% |
2020 | 52.7 M | 0.45% |
2019 | 52.47 M | 0.4% |
2018 | 52.26 M | 1.94% |
2017 | 51.26 M | 3.15% |
2016 | 49.7 M | 1.66% |
2015 | 48.89 M | 13.88% |
2014 | 42.93 M | 23.91% |
2013 | 34.64 M | 30.12% |
2012 | 26.62 M | 1568.54% |
2011 | 1.59 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 4,308.07% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 1,734,076,358 | 3,075.44% | ๐บ๐ธ USA |
Eli Lilly LLY | 949,379,000 | 1,638.50% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,057,000,000 | 3,666.78% | ๐บ๐ธ USA |
Zogenix ZGNX | 55,340,700 | 1.34% | ๐บ๐ธ USA |
United Therapeutics UTHR | 47,000,000 | -13.93% | ๐บ๐ธ USA |